2′-Deoxy-2′-α-fluoro-2′-β-C-methyl 3′,5′-cyclic phosphate nucleotide prodrug analogs as inhibitors of HCV NS5B polymerase: Discovery of PSI-352938

被引：47

作者：

Reddy, P. Ganapati ^{[1
]}

Bao, Donghui ^{[1
]}

Chang, Wonsuk ^{[1
]}

Chun, Byoung-Kwon ^{[1
]}

Du, Jinfa ^{[1
]}

Nagarathnam, Dhanapalan ^{[1
]}

Rachakonda, Suguna ^{[1
]}

Ross, Bruce S. ^{[1
]}

Zhang, Hai-Ren ^{[1
]}

Bansal, Shalini ^{[1
]}

Espiritu, Christine L. ^{[1
]}

Keilman, Meg ^{[1
]}

Lam, Angela M. ^{[1
]}

Niu, Congrong ^{[1
]}

Steuer, Holly Micolochick ^{[1
]}

Furman, Phillip A. ^{[1
]}

Otto, Michael J. ^{[1
]}

Sofia, Michael J. ^{[1
]}

机构：

[1] Pharmasset Inc, Princeton, NJ 08540 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 24期

关键词：

Antiviral; HCV; Nucleoside; Prodrug; Cyclic Phosphate; C VIRUS-REPLICATION; ANTIVIRAL ACTIVITY; HUH-7; CELLS; EFFICIENT; REPLICON; RING; MONOPHOSPHATE; DESIGN;

D O I：

10.1016/j.bmcl.2010.10.035

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of novel 2'-deoxy-2'-alpha-fluoro-2'-beta-C-methyl 3',5'-cyclic phosphate nucleotide prodrug analogs were synthesized and evaluated for their in vitro anti-HCV activity and safety. These prodrugs demonstrated a 10-100-fold greater potency than the parent nucleoside in a cell-based replicon assay due to higher cellular triphosphate levels. Our structure-activity relationship (SAR) studies provided compounds that gave high levels of active triphosphate in rat liver when administered orally to rats. These studies ultimately led to the selection of the clinical development candidate 24a (PSI-352938). (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：7376 / 7380

页数：5

共 50 条

[1] Cyclic phosphate prodrugs of 2′-deoxy-2¢-fluoro-2¢-C-methyl nucleoside analogs as inhibitors of HCV NS5B polymerase
Reddy, P. Ganapati
Bao, Donghui
Chang, Wonsuk
Chun, Byoung-Kwon
Du, Jinfa
Nagarathnam, Dhanapalan
Rachakonda, Suguna
Ross, Bruce S.
Zhang, Hai-Ren
Bansal, Shalini
Espiritu, Christine L.
Keilman, Meg
Lam, Angela M.
Niu, Congrong
Steuer, Holly M.
Furman, Phillip A.
Otto, Michael J.
Sofia, Michael J.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[2] Stereoselective Synthesis of PSI-352938: A β-D-2′-Deoxy-2′-α-fluoro-2′-β-C-methyl-3′,5′-cyclic Phosphate Nucleotide Prodrug for the Treatment of HCV
Reddy, P. Ganapati
Chun, Byoung-Kwon
Zhang, Hai-Ren
Rachakonda, Suguna
Ross, Bruce S.
Sofia, Michael J.
JOURNAL OF ORGANIC CHEMISTRY, 2011, 76 (10): : 3782 - 3790
[3] A 2′-DEOXY-2′-FLUORO-2′-C-METHYL URIDINE CYCLOPENTYL CARBOCYCLIC ANALOG AND ITS PHOSPHORAMIDATE PRODRUG AS INHIBITORS OF HCV NS5B POLYMERASE
Liu, Jian
Du, Jinfa
Wang, Peiyuan
Nagarathnam, Dhanapalan
Espiritu, Christine L.
Bao, Haiying
Murakami, Eisuke
Furman, Phillip A.
Sofia, Michael J.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2012, 31 (04): : 277 - 285
[4] Synthesis of 2′-deoxy-2′-fluoro-2′-C-methyl spiro cyclopentyl carbocyclic uridine analog as potential inhibitors of HCV NS5B polymerase
Singh, Uma S.
Chu, Chung K.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2020, 39 (1-3): : 52 - 68
[5] Inhibition of Hepatitis C Virus Replicon RNA Synthesis by PSI-352938, a Cyclic Phosphate Prodrug of β-D-2′-Deoxy-2′-α-Fluoro-2′-β-C-Methylguanosine
Lam, Angela M.
Espiritu, Christine
Murakami, Eisuke
Zennou, Veronique
Bansal, Shalini
Steuer, Holly M. Micolochick
Niu, Congrong
Keilman, Meg
Bao, Haiying
Bourne, Nigel
Veselenak, Ronald L.
Reddy, P. Ganapati
Chang, Wonsuk
Du, Jinfa
Nagarathnam, Dhanapalan
Sofia, Michael J.
Otto, Michael J.
Furman, Phillip A.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (06) : 2566 - 2575
[6] Nucleotide Prodrugs of 2′-Deoxy-2′-spirooxetane Ribonucleosides as Novel Inhibitors of the HCV NS5B Polymerase
Jonckers, Tim H. M.
Vandyck, Koen
Vandekerckhove, Leen
Hu, Lili
Tahri, Abdellah
Van Hoof, Steven
Lin, Tse-I
Vijgen, Leen
Berke, Jan Martin
Lachau-Durand, Sophie
Stoops, Bart
Leclercq, Laurent
Fanning, Gregory
Samuelsson, Bertil
Nilsson, Magnus
Rosenquist, Asa
Simmen, Kenny
Raboisson, Pierre
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (05) : 1836 - 1844
[7] Discovery of a 2′-fluoro-2′-C-methyl C-nucleotide HCV polymerase inhibitor and a phosphoramidate prodrug with favorable properties
Kirschberg, Thorsten A.
Metobo, Sammy
Clarke, Michael O.
Aktoudianakis, Vangelis
Babusis, Darius
Barauskas, Ona
Birkus, Gabriel
Butler, Thomas
Byun, Daniel
Chin, Gregory
Doerffler, Edward
Edwards, Thomas E.
Fenaux, Martijn
Lee, Rick
Lew, Willard
Mish, Michael R.
Murakami, Eisuke
Park, Yeojin
Squires, Neil H.
Tirunagari, Neeraj
Wang, Ting
Whitcomb, Mark
Xu, Jie
Yang, Huiling
Ye, Hong
Zhang, Lijun
Appleby, Todd C.
Feng, Joy Y.
Ray, Adrian S.
Cho, Aesop
Kim, Choung U.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (08) : 1840 - 1847
[8] Characterization of the intracellular metabolism of β-D-2'-deoxy-2'-fluoro-2'-C-methyl-cytidine and the inhibition of HCV polymerase NS5B by its 5'-triphosphate species
Ma, Han
Jiang, Wen-Rong
Robledo, Nicole
Leveque, Vincent
Ali, Samir
Smith, David
Masjedizadeh, Mohammad
Lara-Jaime, Teresa
Cammack, Nick
Klumpp, Klaus
Symons, Julian
ANTIVIRAL RESEARCH, 2007, 74 (03) : A36 - A36
[9] Mechanism of activation of β-D-2′-deoxy-2′-fluoro-2′-C-methylcytidine and inhibition of hepatitis C virus NS5B RNA polymerase
Murakami, Eisuke
Bao, Haiying
Ramesh, Mangala
McBrayer, Tamara R.
Whitaker, Tony
Steuer, Holly M. Micolochick
Schinazi, Raymond F.
Stuyver, Lieven J.
Obikhod, Aleksandr
Otto, Michael J.
Furman, Phillip A.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (02) : 503 - 509
[10] Synthesis and anti-HCV activity of a new 2′-deoxy-2′-fluoro-2′-C-methyl nucleoside analogue
Hu, Weidong
Wang, Ping'an
Song, Chuanjun
Pan, Zhenliang
Wang, Qiang
Guo, Xiaohe
Yu, Xuejun
Shen, Zhenhua
Wang, Shuyang
Chang, Junbiao
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) : 7297 - 7298

← 1 2 3 4 5 →